openPR Logo
Press release

Pharmacy OneSource Announces Free Webinar with The Joint Commission on Medication Management Standards

10-06-2010 10:35 AM CET | Health & Medicine

Press release from: Pharmacy OneSource

Hospital surveyor to examine hospital pharmacy requirements for upcoming year

Bellevue, WA – Pharmacy OneSource, software-as-a-service provider of Sentri7, the real-time clinical surveillance system, is pleased to announce a complimentary webinar presented by Darryl S. Rich, Pharm.D., a Joint Commission hospital surveyor, on "The Joint Commission Hospital Pharmacy Update for 2011."

Rich will list the three most problematic Medication Management standards in terms of non-compliance by organizations surveyed in hospitals in 2010 and the most common reason why each was scored non-compliant. He will cite the most problematic medication management issues related to radiopharmaceuticals and nuclear medicines.

Additionally, Rich will explain two new changes to the Medication Management standards for 2011, and examine the top three most problematic medication-related National Patient Safety Goals' requirements for hospitals in 2010, including the most common reasons for non-compliance. Finally, he will describe the new requirements for National Patient Safety Goals for medication reconciliation in 2011 and how they differ from the previous requirements.

The Joint Commission Hospital Pharmacy Update for 2011
DATE: Wednesday, October 20, 2010
TIME: 12:00 PM - 1:00 PM EDT
WHERE: http://www.pharmacyonesource.com/webinars

About the Presenter: Darryl Rich is a surveyor for The Joint Commission in the hospital, home care, and ambulatory accreditation programs.  In addition, he works for the Standards Interpretation Group serving as an internal resource for The Joint Commission related to pharmacy and medication management. He previously served as Associate Director for Surveyor Management and Development at The Joint Commission for 11 years.  Dr. Rich has been with The Joint Commission since January 1993. Prior to coming to The Joint Commission, Dr. Rich was National Director of Pharmacy Services for Critical Care America, Inc., a national home infusion company. Previously, he served as Director of Pharmacy Services at Boston University Medical Center. Dr. Rich is active member and Fellow in the American Society of Health System Pharmacists and a past President of the New England Council of Health-System Pharmacists. He has received numerous awards, including a Lifetime Achievement Award in 2009 from the Institute for Safe Medication Practices for his "ongoing contributions to patient safety and having had a major impact on safe medication practices."

About Pharmacy OneSource (www.pharmacyonesource.com)
Pharmacy OneSource is healthcare’s #1 Software-as-a-Service (SaaS) provider. Our more than 80 innovative team members provide best-in-class, SaaS solutions to current and future challenges within health-systems worldwide. Our SaaS solutions contribute to swift and safe healthcare through earlier, easier and better access to data. More than 1,300 healthcare organizations worldwide utilize our HIPAA compliant web-based services: Accupedia, Amplifi, MedBoard, Quantifi, ScheduleRx, Sentri7, Simplifi 797, and VeriForm.

Pharmacy OneSource
3535 Factoria Blvd. SE #440
Bellevue, WA 98006

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacy OneSource Announces Free Webinar with The Joint Commission on Medication Management Standards here

News-ID: 146978 • Views:

More Releases from Pharmacy OneSource

Richie's Specialty Pharmacy Selects Simplifi 797 for USP 797 Compliance
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Richie's Specialty Pharmacy, LLC has selected its Simplifi 797 software for achieving sterile compounding compliance. Simplifi 797 is a web-based application that automates, integrates and streamlines quality activities and documentation related to U.S. Pharmacopeia's Chapter 797 guidelines. The software manages task scheduling for environmental monitoring and automates the reporting of exceptions and compliance. "Simplifi
Pharmacy OneSource® Partners with CriticalPoint™ to Offer the Next Generation …
Bellevue, Washington – Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Pharmacy OneSource® has released a new version of Simplifi 797®, a web-based quality assurance software for USP chapter 797 compounding compliance. The upgraded version of Simplifi 797 includes CriticalPoint's education program, which gives users unlimited access to 42 hours of ACPE-approved continuing education credits supporting compliance with USP Chapter . Lessons
Wolters Kluwer Health Unveils Integration between UpToDate and Sentri7
Bellevue, WA -- Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that UpToDate's clinical knowledge system has been integrated with Sentri7 surveillance software by Pharmacy OneSource. This partnership of evidence-based clinical information through UpToDate and clinical patient surveillance from Sentri7 offers healthcare providers actionable information at the point of care to make better decisions in directing patient care. UpToDate synthesizes the most recent medical

More Releases for Pharm

Fosfomycin Market to Witness Huge Growth by 2026 | Northeast Pharm, Ercros, Shin …
The Latest Released Fosfomycin market study has evaluated the future growth potential of Global Fosfomycin market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunities
Clopidol Market updates, demand analysis, and expected growth forecast 2021-2027 …
Global “Clopidol” Market Size, Status, and Forecast 2021-2027. In-depth research accumulated to offer Latest insights about acute features of the global Clopidol market. This report provides a detailed overview of key factors in the Clopidol Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development. The effect of the COVID-19 outbreak at the enterprise turned into completely assessed. Fully chance evaluation and enterprise recommendations
Paromomycin Market updates, demand analysis, and expected growth forecast 2021-2 …
The new study on the Global “Paromomycin Market” 2021-2027 analyzes the crucial capabilities, key infrastructures, major organizations, evaluates measures to attain potential success in the Paromomycin industry. Because of the in-depth overview of the Global Paromomycin market, the recent papers allow investors, traders, and manufacturers to plan some innovative techniques, and meanwhile, align them with operational and commercial enterprise models. Additionally, the Paromomycin market report offers crucial facets at the
Clopidol Market updates, demand analysis and expected growth forecast 2021-2027 …
The “Clopidol” Market report mainly studies the size, recent trends, and development status of the Clopidol market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain, and competitive landscape. Technological innovation and advancement will further enhance the performance of the product, making it more broadly used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for
Perphenazine Market Overall Study Report 2020-2027 | Players Sandoz, Actavis, Qu …
The latest report added by Stratagem Market Insights gives deep insights into the drivers and restraints in the Worldwide Perphenazine Market. The research report "Global Perphenazine Market Size and Growth Forecast to 2027" provide a comprehensive take on the overall market. Analysts have carefully evaluated the milestones achieved by the global Perphenazine market and the current trends that are likely to shape its future. Primary and secondary research methodologies have
Global Polygeline Injection Market Forecast 2018-2025 Abbott, Shengtai Pharm, BB …
A detailed market study on "Global Polygeline Injection Market" examines the performance of the Polygeline Injection market. It encloses an in-depth Research of the Polygeline Injection market state and the competitive landscape globally. This report analyzes the potential of Polygeline Injection market in the present and the future prospects from various angles in detail. The Global Polygeline Injection Market 2018 report includes Polygeline Injection market Revenue, market Share, Polygeline Injection industry